The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase Ib trial in the U.S. of salvage CT041 CLDN18.2-specific chimeric antigen receptor T-cell therapy for patients with advanced gastric and pancreatic adenocarcinoma.
 
Gregory P. Botta
Honoraria - Natera
Consulting or Advisory Role - Natera
Speakers' Bureau - Natera
 
Carlos Roberto Becerra
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Bayer; HERON; Ipsen; SOBI; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Taiho Pharmaceutical
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); QED Therapeutics (Inst)
 
Dae Won Kim
Research Funding - Bold Therapeutics
 
Dan Zhao
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Fulgent Genetics; G1 THerapeutics; GlaxoSmithKline; Isofol Medical; Jazz Pharmaceuticals; Merck Serono; Oncocyte; Roche
Consulting or Advisory Role - Bayer; BMS; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono
 
Hong Ma
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
 
Audrey Ween
No Relationships to Disclose
 
Petra Acha
No Relationships to Disclose
 
Zonghai Li
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
 
Harry H. Yoon
Consulting or Advisory Role - ALX ONCOLOGY; Astellas Scientific and Medical Affairs Inc; AstraZeneca; BeiGene; Bristol-Myers Squibb; LSK Biopharma; Macrogenics; Merck; Novartis; OncXerna Therapeutics; Zymeworks
Research Funding - Boston Biomedical (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly